AlloSource appoints Kerr Holbrook to be chief commercial officer
Monday May 18, 2015
CENTENNIAL -- AlloSource, a leading provider of cartilage, cellular, bone, skin and soft tissue allografts for use in surgical procedures and wound care to advance patient healing, announced the appointment of Kerr Holbrook as chief commercial officer.
Holbrook has more than 25 years of experience in a variety of sales, marketing and business development positions for health care service and manufacturing companies.
He also has extensive experience bringing products to market, including collaborating with research and development, creating commercialization plans and managing their implementation.
As chief commercial officer, Holbrook will oversee AllSource’s commercialization strategy and organization, including distribution channels and customer service both domestic and international.
“Kerr’s accomplished background and collaborative approach will enhance AlloSource’s growth and our vision for the future,” said Thomas Cycyota, AlloSource president and CEO.
“His experience with strategic business development will help us ensure donated tissue reaches patients in need.”
“Joining the leadership team at AlloSource is a great privilege,” Holbrook said. “Being a part of this growing, innovative company provides an opportunity to contribute to an industry that is continually in need of biologic solutions for doctors and their patients.”